A. Eroğlu, "Comparison of the ICU admission rate and mortalities of COVID-19 patients who received hydroxychloroquine and favipiravir in the ward," KSCCM-ACCC 2021 , Seoul, South Korea, pp.222-223, 2021
Eroğlu, A. 2021. Comparison of the ICU admission rate and mortalities of COVID-19 patients who received hydroxychloroquine and favipiravir in the ward. KSCCM-ACCC 2021 , (Seoul, South Korea), 222-223.
Eroğlu, A., (2021). Comparison of the ICU admission rate and mortalities of COVID-19 patients who received hydroxychloroquine and favipiravir in the ward . KSCCM-ACCC 2021 (pp.222-223). Seoul, South Korea
Eroğlu, AHMET. "Comparison of the ICU admission rate and mortalities of COVID-19 patients who received hydroxychloroquine and favipiravir in the ward," KSCCM-ACCC 2021, Seoul, South Korea, 2021
Eroğlu, AHMET. "Comparison of the ICU admission rate and mortalities of COVID-19 patients who received hydroxychloroquine and favipiravir in the ward." KSCCM-ACCC 2021 , Seoul, South Korea, pp.222-223, 2021
Eroğlu, A. (2021) . "Comparison of the ICU admission rate and mortalities of COVID-19 patients who received hydroxychloroquine and favipiravir in the ward." KSCCM-ACCC 2021 , Seoul, South Korea, pp.222-223.
@conferencepaper{conferencepaper, author={AHMET EROĞLU}, title={Comparison of the ICU admission rate and mortalities of COVID-19 patients who received hydroxychloroquine and favipiravir in the ward}, congress name={KSCCM-ACCC 2021}, city={Seoul}, country={South Korea}, year={2021}, pages={222-223} }